Cas No.: | 2225892-70-4 |
Chemical Name: | ATX inhibitor 1 |
Synonyms: | ATX inhibitor 1;(4-(1-(((3,5-Dichlorobenzyl)oxy)carbonyl)piperidine-4-carboxamido)benzyl)phosphonicacid;(4-(1-(((3,5-Dichlorobenzyl)oxy)carbonyl)piperidine-4-carboxamido)benzyl)phosphonic acid;[4-[[1-[(3,5-dichlorophenyl)methoxycarbonyl]piperidine-4-carbonyl]amino]phenyl]methylphosphonic acid;BDBM50458125;E74832 |
SMILES: | ClC1C=C(C=C(C=1)COC(N1CCC(C(NC2C=CC(CP(=O)(O)O)=CC=2)=O)CC1)=O)Cl |
Formula: | C21H23Cl2N2O6P |
M.Wt: | 501.296884775162 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Publication: | [1]. Balupuri A, et al. Discovery and optimization of ATX inhibitors via modeling, synthesis and biological evaluation. Eur J Med Chem. 2018 Mar 25;148:397-409. |
Description: | ATX inhibitor 1 is a potent ATX (IC50=1.23 nM, FS-3 and 2.18 nM, bis-pNPP) inhibitor. |
Target: | IC50: 1.23 nM (FS-3) and 2.18 nM (bis-pNPP)[1] |
References: | [1]. Balupuri A, et al. Discovery and optimization of ATX inhibitors via modeling, synthesis and biological evaluation. Eur J Med Chem. 2018 Mar 25;148:397-409. |